Vineet Laboratories

Vineet Laboratories FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Vineet Laboratories (VINEETLAB.NS) as of Nov 3, 2026 is -1,621.34 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -51.73 % — a change of 3,033.95% (lower).

FCF Conversion

-1,621.34 %

YoY

3,033.95%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Vineet Laboratories is 2026 -1,621.34 % . FCF Conversion Rate (FCF/EBITDA) of Vineet Laboratories was 2025 -51.73 % . It decreases by 3,033.95% lower compared to the previous year.

The Vineet Laboratories FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2020
68,791.79 INR
Jan 1, 2021
-1,125.93 INR
Jan 1, 2022
30.22 INR
Jan 1, 2023
-1,377.17 INR
Jan 1, 2024
-666.46 INR
Jan 1, 2025
-51.73 INR
Jan 1, 2026
-1,621.34 INR
The Vineet Laboratories FCF Conversion history
YEARFCF ConversionYoY
-1,621.34 %+3,033.95%
-51.73 %-92.24%
-666.46 %-51.61%
-1,377.17 %-4,657.56%
30.22 %-102.68%
-1,125.93 %-101.64%
68,791.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vineet Laboratories Stock analysis

What does Vineet Laboratories do? Vineet Laboratories Ltd is a Hyderabad-based company operating in the Health Care sector, specifically within the pharmaceutical industry. Listed on the Indian stock exchange in June 2021, the firm specializes in the production and export of pharmaceutical intermediates and fine chemicals. Its portfolio of active pharmaceutical ingredient intermediates includes Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Additionally, the company manufactures various fine chemicals and reagents such as Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, and n-Butyl Lithium. Vineet Laboratories also offers custom synthesis molecules to international markets. Vineet Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vineet Laboratories stock

FCF Conversion Rate (FCF/EBITDA) of Vineet Laboratories is -1,621.34 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Vineet Laboratories changed from -51.73 % to -1,621.34 %, representing a 3,033.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Vineet Laboratories since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Vineet Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Vineet Laboratories

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Vineet Laboratories